Your browser doesn't support javascript.
loading
Correction: Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma.
Gkotzamanidou, M; Sfikakis, P P; Kyrtopoulos, S A; Bamia, C; Dimopoulos, M A; Souliotis, V L.
Afiliação
  • Gkotzamanidou M; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA.
  • Sfikakis PP; Department of Clinical Therapeutics, University of Athens School of Medicine, 11528, Athens, Greece.
  • Kyrtopoulos SA; First Department of Propedeutic Medicine, University of Athens School of Medicine, 11527, Athens, Greece.
  • Bamia C; Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, 48 Vassileos Constantinou Avenue, 11635, Athens, Greece.
  • Dimopoulos MA; Department of Hygiene, Epidemiology and Medical Statistics, University of Athens School of Medicine, 11527, Athens, Greece.
  • Souliotis VL; Department of Clinical Therapeutics, University of Athens School of Medicine, 11528, Athens, Greece.
Br J Cancer ; 122(11): 1727-1728, 2020 May.
Article em En | MEDLINE | ID: mdl-32246070
ABSTRACT
An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article